Accueil>>Signaling Pathways>> Immunology/Inflammation>> NF-κB>>Benzoyloxypaeoniflorin

Benzoyloxypaeoniflorin

Catalog No.GC35494

La benzoyloxypaeoniflorine, isolée de la racine de Paeonia suffruticosa, est un inhibiteur de tyrosinase contre la tyrosinase de champignon avec une IC50 de 0,453 mM.

Products are for research use only. Not for human use. We do not sell to patients.

Benzoyloxypaeoniflorin Chemical Structure

Cas No.: 72896-40-3

Taille Prix Stock Qté
1mg
112,00 $US
En stock
5mg
468,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Benzoyloxypaeoniflorin, isolated from the root of Paeonia suffruticosa, is a tyrosinase inhibitor against mushroom tyrosinase with IC50 of 0.453 mM. Benzoyloxypaeoniflorin is NF-κB Inhibitor and contributes to improving blood circulation through its inhibitory effect on both platelet aggregation and blood coagulation[1][2][3]. IC50: 0.453 mM (Mushroom tyrosinase)[1]NF-κB[2]

[1]. Ding HY, et al. Tyrosinase inhibitors isolated from the roots of Paeonia suffruticosa. J Cosmet Sci. 2009 May-Jun;60(3):347-52. [2]. Lu Y, et al. The Screening Research of NF-κB Inhibitors from Moutan Cortex Based on Bioactivity-Integrated UPLC-Q/TOF-MS. Evid Based Complement Alternat Med. 2019 Mar 3;2019:6150357. [3]. Koo YK, et al. Platelet anti-aggregatory and blood anti-coagulant effects of compounds isolated from Paeonia lactiflora and Paeonia suffruticosa. Pharmazie. 2010 Aug;65(8):624-8.

Avis

Review for Benzoyloxypaeoniflorin

Average Rating: 5 ★★★★★ (Based on Reviews and 12 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Benzoyloxypaeoniflorin

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.